-
2
-
-
4344698931
-
-
For the antihypertensive activity, see
-
H. A. Priestap Phytochemistry 1985 24 848
-
(1985)
Phytochemistry
, vol.24
, pp. 848
-
-
Priestap, H.A.1
-
7
-
-
84863093897
-
-
For the anesthetic activity, see: Laboratori Baldacci, 5,946,268,; Chem. Abstr., 1984
-
For the anesthetic activity, see: Laboratori Baldacci, S. P. A. Japanese Patent 5,946,268, 1984; Chem. Abstr., 1984, 101, 54922
-
(1984)
S. P. A. Japanese Patent
, vol.101
, pp. 54922
-
-
-
8
-
-
84863112232
-
-
For the antiulcer activity, see:,; Chem. Abstr., 1981, 95, 61988 For anxiolytic activity, see: Pazinaclone
-
For the antiulcer activity, see: W. Lippmann, U.S. Patent 4,267,189, 1981; Chem. Abstr., 1981, 95, 61988
-
(1981)
Chem. Abstr.
, pp. 4267189
-
-
Lippmann, W.1
-
12
-
-
0029011730
-
-
For the antileukemic activity, see
-
E. De Clercq J. Med. Chem. 1995 38 2491
-
(1995)
J. Med. Chem.
, vol.38
, pp. 2491
-
-
De Clercq, E.1
-
14
-
-
0004121625
-
-
For other interesting biological properties see also:, 3rd edn, Churchill-Livingstone, London
-
For other interesting biological properties see also: H. P. Rang, M. M. Dale, J. M. Ritter, in Pharmacology, 3rd edn, Churchill-Livingstone, London, 1995
-
(1995)
Pharmacology
-
-
Rang, H.P.1
Dale, M.M.2
Ritter, J.M.3
-
15
-
-
0029793981
-
-
M. Anzini A. Cappelli S. Vomero G. Giorgi T. Langer G. Bruni M. R. Romeo A. S. Basile J. Med. Chem. 1996 36 4275
-
(1996)
J. Med. Chem.
, vol.36
, pp. 4275
-
-
Anzini, M.1
Cappelli, A.2
Vomero, S.3
Giorgi, G.4
Langer, T.5
Bruni, G.6
Romeo, M.R.7
Basile, A.S.8
-
16
-
-
0025305395
-
-
M. Reiffen W. Eberlein P. Mueller M. Psiorz K. Noll J. Heider C. Lillie W. Kobinger P. Luger J. Med. Chem. 1990 33 1496
-
(1990)
J. Med. Chem.
, vol.33
, pp. 1496
-
-
Reiffen, M.1
Eberlein, W.2
Mueller, P.3
Psiorz, M.4
Noll, K.5
Heider, J.6
Lillie, C.7
Kobinger, W.8
Luger, P.9
-
20
-
-
79960253288
-
-
Some recent examples of non-asymmetric metal catalysed isoindolinone formation
-
V. Machtey H. E. Gottlieb G. Byk ARKIVOC 2011 9 308
-
(2011)
ARKIVOC
, vol.9
, pp. 308
-
-
MacHtey, V.1
Gottlieb, H.E.2
Byk, G.3
-
27
-
-
0032537535
-
-
T. R. Belliotti W. A. Brink S. R. Kestern J. R. Rubin D. J. Wistrow K. T. Zoski S. Z. Whetzel A. E. Corbin T. A. Pugsley T. G. Heffner L. D. Wise Bioorg. Med. Chem. Lett. 1998 8 1499
-
(1998)
Bioorg. Med. Chem. Lett.
, vol.8
, pp. 1499
-
-
Belliotti, T.R.1
Brink, W.A.2
Kestern, S.R.3
Rubin, J.R.4
Wistrow, D.J.5
Zoski, K.T.6
Whetzel, S.Z.7
Corbin, A.E.8
Pugsley, T.A.9
Heffner, T.G.10
Wise, L.D.11
-
39
-
-
84857456599
-
-
V. More A. Di Mola G. Croce C. Tedesco C. Petronzi P. De Caprariis A. Peduto R. Filosa A. Massa Org. Biomol. Chem. 2011 9 8483
-
(2011)
Org. Biomol. Chem.
, vol.9
, pp. 8483
-
-
More, V.1
Di Mola, A.2
Croce, G.3
Tedesco, C.4
Petronzi, C.5
De Caprariis, P.6
Peduto, A.7
Filosa, R.8
Massa, A.9
-
43
-
-
44349168328
-
-
For selected examples on conjugated addition reactions with bifunctional cinchona-thiourea catalysts, see
-
S. J. Connon Chem. Commun. 2008 2499
-
(2008)
Chem. Commun.
, pp. 2499
-
-
Connon, S.J.1
-
53
-
-
79958185446
-
-
No improvement of the enantioselectivity with quinine as catalyst was observed by changing the reaction conditions or using different alkaloids such as cupreidine, quinidine, cinchonine and cinchonidine (see supporting information for details)
-
J. Aleman A. Parra H. Jiang K. A. Jorgensen Chem.-Eur. J. 2011 17 6890
-
(2011)
Chem.-Eur. J.
, vol.17
, pp. 6890
-
-
Aleman, J.1
Parra, A.2
Jiang, H.3
Jorgensen, K.A.4
|